China’s inactivated COVID-19 vaccine protects animals from disease

0
4
Facebook
Twitter
Pinterest
WhatsApp

Inactivated vaccines use the killed version of the germ that causes disease (representational)

Beijing:

China’s COVID-19 inactivated vaccine has shown protection against coronavirus infection in animal experiments, Xinhua reported citing a study published in the journal Cell.

Inactivated vaccines use the killed version of the germ that causes disease.

Research on the BBIBP-CorV candidate vaccine is being carried out by the Beijing Biological Products Institute within the framework of the Chinese National Group Biotec, the Chinese Center for Disease Control and Prevention, the Chinese Academy of Medical Sciences as well as ‘other institutions.

According to Xinhua, the researchers said that pilot-scale production of the vaccine candidate induces high levels of neutralizing antibody concentrations in mice, rats, guinea pigs, rabbits and non-human primates, including including cynomolgus monkeys and rhesus macaques. Antibodies help provide protection against SARS-CoV-2.

Chinese Science and Technology Minister Wang Zhigang said at a press conference on Sunday that the country would make its COVID-19 vaccine “a global public good” when it was ready to be applied.

A neutralizing antibody can defend a cell against a pathogen or an infectious particle by canceling out any biological effect.

In addition, research shows that the vaccine has high productivity and good genetic stability for manufacturing, which will help further evaluation in a clinical trial.

The coronavirus that first appeared in China has so far killed 409,437 people worldwide. The virus has infected 7,232,313 people worldwide.

The inactivated candidate vaccine was approved for clinical trials in late April, according to the China National Biotec Group.

Beijing is currently working to develop COVID-19 vaccines in five categories: inactivated vaccines, recombinant protein vaccines, live attenuated influenza vaccines, adenovirus vaccines and nucleic acid vaccines.

To date, four inactivated vaccines and one adenovirus vaccine have been approved for clinical trials.

(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)

LEAVE A REPLY

Please enter your comment!
Please enter your name here